Breaking News Instant updates and real-time market news.

BOLD

Audentes Therapeutics

$24.65

0.36 (1.48%)

09:28
01/11/19
01/11
09:28
01/11/19
09:28

Audentes accelerated approval in 2020 a possibility, says H.C. Wainwright

Potential accelerated approval for Audentes Therapeutics's AT132 during 2020 is "viable, highly desirable, and imminently pursuable," H.C. Wainwright analyst Debjit Chattopadhyay tells investors in a research note titled "AT132 Accelerated Approval During 2020 Is Well Within the Realm of Possibilities." While management is not guiding to it, the data thus far supports the underlying premise for accelerated approval, says Chattopadhyay. He believes the Q3 of 2019 update from additional patients is likely to establish AT132 "not only as the first but best in class gene therapy" for X-linked myotubular myopathy. The analyst keeps a Buy rating on Audentes Therapeutics with a $33 price target.

BOLD Audentes Therapeutics
$24.65

0.36 (1.48%)

11/07/18
11/07/18
DOWNGRADE

On The Fly: Top five analyst downgrades
Catch up on today's top five analyst downgrades with this list compiled by The Fly: 1. Freeport McMoRan (FCX) downgraded to Underperform from Sector Perform at RBC Capital with analyst Stephen Walker saying he points to the company's premium valuation ahead of what he expects to be a decline in 2019 production. 2. Zillow (Z, ZG) downgraded to Sell from Hold at Zelman and to Negative from Neutral at Susquehanna. 3. Mindbody (MB) downgraded to Neutral from Buy at UBS and Roth Capital as well as to Neutral from Overweight at JPMorgan. 4. Frontier Communications (FTR) downgraded to Sell from Neutral at UBS with analyst Batya Levi saying Frontier's free cash flow remains under pressure. 5. Audentes downgraded to Market Perform from Outperform at William Blair with analyst Raju Prasad saying increased competition in Pompe disease is giving him pause. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
11/26/18
JPMS
11/26/18
INITIATION
Target $35
JPMS
Overweight
Audentes Therapeutics initiated with an Overweight at JPMorgan
JPMorgan analyst Anupam Rama started Audentes Therapeutics with an Overweight rating and $35 price target. The stock has pulled 40% since early October, which represents an attractive long-term entry point, Rama tells investors in a research note. He believes the "de-risked nature" of the known clinical data for gene therapy lead assets AT132 in X-Linked Myotubular Myopathy and AT342 in Crigler-Najjar Syndrome "goes underappreciated" at current share levels.
01/11/19
GUGG
01/11/19
UPGRADE
GUGG
Buy
Audentes Therapeutics upgraded to Buy from Neutral at Guggenheim
01/11/19
GUGG
01/11/19
UPGRADE
Target $35
GUGG
Buy
Audentes Therapeutics upgraded to Buy at Guggenheim on positive AT132 outlook
As reported earlier, Guggenheim analyst Whitney Ijem upgraded Audentes Therapeutics to Buy from Neutral with a price target of $35 at the conclusion of the JPMorgan Healthcare conference this week. The analyst says that he is "incrementally more positive" on the company's A132 program after the meeting, anticipating "productive regulatory and data updates in the near term." Ijem further expects 2019 to be a year of of "pipeline progress" for Audentes Therapeutics now that the Pompe program is "back on track" and ahead of more details about a larger neuromuscular indication.

TODAY'S FREE FLY STORIES

03:55
01/17/19
01/17
03:55
01/17/19
03:55
General news
FX Action: USD-CAD a posted a three-day high »

FX Action: USD-CAD a…

03:00
01/17/19
01/17
03:00
01/17/19
03:00
General news
FX Update: An abatement in risk appetite has impacted currencies »

FX Update: An abatement…

01:50
01/17/19
01/17
01:50
01/17/19
01:50
General news
Asian Market Wrap: »

Asian Market Wrap:…

RVNC

Revance

$18.11

-2.11 (-10.44%)

21:05
01/16/19
01/16
21:05
01/16/19
21:05
Syndicate
Revance 5.9M share Secondary priced at $17.00 »

Goldman Sachs, Cowen and…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Jan

MRTX

Mirati Therapeutics

$62.51

-2.33 (-3.59%)

20:49
01/16/19
01/16
20:49
01/16/19
20:49
Syndicate
Mirati Therapeutics 1.6M share Spot Secondary priced at $62.00 »

The deal priced at the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Jan

BREW

Craft Brew

$15.50

0.19 (1.24%)

20:45
01/16/19
01/16
20:45
01/16/19
20:45
Initiation
Craft Brew initiated at Maxim »

Craft Brew initiated with…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ROX

Castle Brands

$0.91

0.0122 (1.36%)

20:41
01/16/19
01/16
20:41
01/16/19
20:41
Initiation
Castle Brands initiated at Maxim »

Castle Brands initiated…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

PRT

PermRock Royalty Trust

$9.61

-0.39 (-3.90%)

20:39
01/16/19
01/16
20:39
01/16/19
20:39
Downgrade
PermRock Royalty Trust rating change at Stifel »

PermRock Royalty Trust…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

GBCI

Glacier Bancorp

$42.87

1.36 (3.28%)

20:38
01/16/19
01/16
20:38
01/16/19
20:38
Hot Stocks
Glacier Bancorp acquires FNB Bancorp »

Glacier Bancorp announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Feb

  • 26

    Feb

  • 27

    Feb

  • 12

    Mar

ERJ

Embraer

$22.81

-0.59 (-2.52%)

20:34
01/16/19
01/16
20:34
01/16/19
20:34
Downgrade
Embraer rating change at Morgan Stanley »

Embraer downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AICAF

Air China

$0.00

(0.00%)

20:32
01/16/19
01/16
20:32
01/16/19
20:32
Upgrade
Air China rating change at HSBC »

Air China upgraded to Buy…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CEA

China Eastern Airlines

$28.64

-0.09 (-0.31%)

20:26
01/16/19
01/16
20:26
01/16/19
20:26
Upgrade
China Eastern Airlines rating change at HSBC »

China Eastern Airlines…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MS

Morgan Stanley

$44.48

1.59 (3.71%)

, BBT

BB&T

$47.55

1.2 (2.59%)

20:25
01/16/19
01/16
20:25
01/16/19
20:25
Earnings
Notable companies reporting before tomorrow's open »

Notable companies…

MS

Morgan Stanley

$44.48

1.59 (3.71%)

BBT

BB&T

$47.55

1.2 (2.59%)

PPG

PPG

$102.58

1.58 (1.56%)

MTB

M&T Bank

$154.45

3.04 (2.01%)

KEY

KeyCorp

$16.75

0.44 (2.70%)

FAST

Fastenal

$54.11

-0.47 (-0.86%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Jan

  • 17

    Jan

  • 17

    Jan

  • 17

    Jan

  • 17

    Jan

  • 17

    Jan

  • 11

    Feb

  • 23

    May

  • 18

    Oct

FDC

First Data

$21.27

3.72 (21.20%)

20:07
01/16/19
01/16
20:07
01/16/19
20:07
Downgrade
First Data rating change at Goldman Sachs »

First Data downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 03

    Mar

VEON

Veon

$2.56

-0.03 (-1.16%)

19:44
01/16/19
01/16
19:44
01/16/19
19:44
Downgrade
Veon rating change at VTB Capital »

Veon downgraded to Hold…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AMZN

Amazon.com

$1,682.84

7.84 (0.47%)

19:22
01/16/19
01/16
19:22
01/16/19
19:22
Hot Stocks
Amazon announces AWS Backup service »

Amazon Web Service, an…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 16

    Jan

  • 28

    Jan

  • 20

    Feb

  • 03

    Mar

GS

Goldman Sachs

$197.03

17.12 (9.52%)

19:09
01/16/19
01/16
19:09
01/16/19
19:09
Periodicals
WSJ's "Heard on the Street" column says to look past Goldman Sachs Q4 glitter »

The Wall Street…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 03

    Mar

TSLA

Tesla

$346.03

1.78 (0.52%)

18:57
01/16/19
01/16
18:57
01/16/19
18:57
Periodicals
CA makes up large portion of Tesla Model 3 registrations in 2018, Bloomberg says »

The state of California…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 16

    Jan

CARS

Cars.com

$23.14

-0.26 (-1.11%)

, MNKD

MannKind

$1.32

-0.06 (-4.35%)

18:46
01/16/19
01/16
18:46
01/16/19
18:46
Hot Stocks
Fly Intel: After Hours Movers »

HIGHER: Cars.com (CARS)…

CARS

Cars.com

$23.14

-0.26 (-1.11%)

MNKD

MannKind

$1.32

-0.06 (-4.35%)

FOLD

Amicus

$12.18

0.19 (1.58%)

FUL

H.B. Fuller

$43.35

0.09 (0.21%)

PLXS

Plexus

$54.88

1.195 (2.23%)

CSX

CSX

$65.36

0.27 (0.41%)

KMI

Kinder Morgan

$17.46

0.15 (0.87%)

AA

Alcoa

$29.02

0.13 (0.45%)

ACB

Aurora Cannabis

$7.33

0.35 (5.01%)

MRTX

Mirati Therapeutics

$62.51

-2.33 (-3.59%)

AAPL

Apple

$154.88

1.84 (1.20%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 16

    Jan

  • 16

    Jan

  • 16

    Jan

  • 17

    Jan

  • 17

    Jan

  • 29

    Jan

  • 29

    Jan

  • 10

    Feb

  • 11

    Feb

  • 26

    Feb

  • 27

    Feb

  • 28

    May

  • 17

    Jan

BAC

Bank of America

$28.44

1.89 (7.12%)

18:46
01/16/19
01/16
18:46
01/16/19
18:46
Periodicals
BofA's global investment banking head to leave bank, FT reports »

Bank of America's…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 16

    Jan

  • 12

    Feb

  • 03

    Mar

NEWR

New Relic

$90.47

1.38 (1.55%)

18:44
01/16/19
01/16
18:44
01/16/19
18:44
Hot Stocks
New Relic CEO: 'We are an app-centric company' »

In an interview on…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Jan

  • 24

    Jan

  • 25

    Jan

  • 06

    Feb

  • 25

    Feb

  • 14

    Mar

TME

Tencent Music

$12.99

0.57 (4.59%)

18:33
01/16/19
01/16
18:33
01/16/19
18:33
Initiation
Tencent Music initiated at JPMorgan »

Tencent Music initiated…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ASCMA

Ascent Capital

$0.40

-0.0499 (-11.09%)

18:27
01/16/19
01/16
18:27
01/16/19
18:27
Hot Stocks
Ascent Capital announces strategic review »

Ascent Capital Group…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CMS

CMS Energy

$50.56

0.34 (0.68%)

18:19
01/16/19
01/16
18:19
01/16/19
18:19
Initiation
CMS Energy initiated at Goldman Sachs »

CMS Energy initiated with…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 10

    Feb

DTE

DTE Energy

$111.73

0.48 (0.43%)

18:15
01/16/19
01/16
18:15
01/16/19
18:15
Initiation
DTE Energy initiated at Goldman Sachs »

DTE Energy initiated with…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.